Soo-Jin Kim

Hoofd Techniek/Wetenschap/O&O bij INOZYME PHARMA, INC.

Vermogen: 2 M $ op 31-05-2024

Health Technology

Consumer Services

Actieve functies van Soo-Jin Kim

Bedrijven	Functie	Begin	Einde
INOZYME PHARMA, INC.	Hoofd Techniek/Wetenschap/O&O	08-03-2022	-

Bedrijven	Functie	Begin	Einde
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Corporate Officer/Principal	-	-
HANMI PHARM. CO., LTD.	Corporate Officer/Principal	-	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-	-

Cornell University	Undergraduate Degree
California Institute of Technology	Doctorate Degree

Internationaal

Verenigde Staten	6
Zuid-Korea	2

Operationeel

Corporate Officer/Principal	3
Undergraduate Degree	1
Doctorate Degree	1

Sectoraal

Health Technology	5
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
HANMI PHARM. CO., LTD.	Health Technology
INOZYME PHARMA, INC.	Health Technology

Bedrijven in privébezit	1
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology

Bedrijven in privébezit

Health Technology